COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 2438: Articles 24371-24380  | Next

Staff testing for COVID-19 via an online pre-registration form
Moolla, M. S., Parker, A., Parker, M. A., Sithole, S., Amien, L., Chiecktey, R., Bawa, T., Mowlana, A.
10.1101/2020.07.13.20152876 — Posted: 2020-07-14
At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR based tests?: A systematic review of individual participant data
Mallett, S., Allen, J., Graziadio, S., Taylor, S. A., Sakai, N. S., Green, K., Suklan, J., Hyde, C., Shinkins, B., Zhelev, Z., Peters, J., Turner, P., Roberts, N. W., Ferrante di Ruffano, L., Wolff, R., Whiting, P., Winter, A., Bhatnagar, G., Nicholson, B. D., Halligan, S.
10.1101/2020.07.13.20152793 — Posted: 2020-07-14
Identifying Key Determinants of SARS-CoV-2/ACE2 Tight Interaction
Ngo, V. A., Jha, R. K.
10.1101/2020.07.13.199562 — Posted: 2020-07-13 Discussion: Onsite
Worldwide Geographical and Temporal Analysis of SARS-CoV-2 Haplotypes shows Differential Distribution Patterns
Justo Arevalo, S., Zapata Sifuentes, D., Huallpa Robles, C., Landa Bianchi, G., Castillo Chavez, A., Garavito-Salini Casas, R., Uceda-Campos, G., Pineda Chavarria, R.
10.1101/2020.07.12.199414 — Posted: 2020-07-13
Comparisons of the genome of SARS-CoV-2 and those of other betacoronaviruses
Rodriguez-Roman, E., Gibbs, A. J.
10.1101/2020.07.12.199521 — Posted: 2020-07-13
Modulating the transcriptional landscape of SARS-CoV-2 as an effective method for developing antiviral compounds
Hoagland, D. A., Clarke, D. J. B., Moeller, R., Han, Y., Yang, L., Wojciechowicz, M. L., Lachmann, A., Oguntuyo, K. Y., Stevens, C., Lee, B., Chen, S., Ma'ayan, A., tenOever, B. R.
10.1101/2020.07.12.199687 — Posted: 2020-07-13
Single-cell analysis reveals the function of lung progenitor cells in COVID-19 patients
Zuo, W., Zhao, Z., Zhao, Y., Zhou, Y., Wang, X., Zhang, T.
10.1101/2020.07.13.200188 — Posted: 2020-07-13
PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2.
Theise, N. D., Arment, A. R., Chakravarty, D., Gregg, J. M. H., Jacobson, I. M., Jung, K. H., Nair, S. S., Tiwari, A., Thurston, A. W., Van Drie, J., Westover, J. B.
10.1101/2020.07.12.199505 — Posted: 2020-07-13
Tobacco, but not nicotine and flavor-less electronic cigarettes, induces ACE2 and immune dysregulation
Lee, A. C., Chakladar, J., Li, W. T., Chen, C., Chang, E. Y., Wang-Rodriguez, J., Ongkeko, W. M.
10.1101/2020.07.13.198630 — Posted: 2020-07-13
Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses
Hoepel, W., Chen, H.-J., Allahverdiyeva, S., Manz, X., Aman, J., Bonta, P., Brouwer, P., de Taeye, S., Caniels, T., van der Straten, K., Golebski, K., Griffith, G., Jonkers, R., Larsen, M., Linty, F., Neele, A., Nouta, J., van Baarle, F., van Drunen, C., Vlaar, A., de Bree, G., Sanders, R., Willemsen, L., Wuhrer, M., Bogaard, H. J., van Gils, M., Vidarsson, G., de Winther, M. P. J., den Dunnen, J.
10.1101/2020.07.13.190140 — Posted: 2020-07-13 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).